| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers L > Headlines for Lifeline Therapeutics, Inc. > News item |
New Issue: Lifeline Therapeutics closes $8 million private placement of stock
New York, June 1 - Lifeline Therapeutics, Inc. said it completed an $8 million private placement of stock.
Keating Securities, LLC was placement agent.
Proceeds will be used to repay the company's $3 million of debt and for research on the company's Protandim product and for working capital.
Lifeline, based in Denver, produces dietary supplements used to combat aging.
No further details of the placement were disclosed.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.